Precigen to Participate in Guggenheim Healthcare Talks Oncology Day

Rhea-AI Summary

Precigen, Inc. (Nasdaq: PGEN) announced that Dr. Helen Sabzevari, President and CEO, will participate in a virtual fireside chat at the Guggenheim Healthcare Talks Oncology Day on February 12, 2021, at 11:30 AM ET. Investors can access the live webcast through Precigen's website in the Events & Presentations section. Precigen focuses on innovative gene and cell therapies targeting serious diseases, with an emphasis on immuno-oncology, autoimmune disorders, and infectious diseases. For more information, visit www.precigen.com.

GERMANTOWN, Md., Feb. 4, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will participate in a virtual fireside chat at the Guggenheim Healthcare Talks Oncology Day on Friday, February 12, 2021 at 11:30 AM ET. 

Participants may access the live webcast of the virtual event through Precigen's website in the Events & Presentations section at investors.precigen.com/events-presentations.

Precigen: Advancing Medicine with Precision^™
Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization. For more information about Precigen, visit www.precigen.com or follow us on Twitter @Precigen and LinkedIn.

 

Investor Contact:			Media Contact:
Steven Harasym			Glenn Silver
Vice President, Investor Relations			Lazar-FINN Partners
Tel: +1 (301) 556-9850			glenn.silver@finnpartners.com
investors@precigen.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/precigen-to-participate-in-guggenheim-healthcare-talks-oncology-day-301222576.html

SOURCE Precigen, Inc.

FAQ

What is Precigen participating in on February 12, 2021?

Precigen will participate in a virtual fireside chat at the Guggenheim Healthcare Talks Oncology Day.

Who is representing Precigen at the Guggenheim Healthcare Talks?

Dr. Helen Sabzevari, President and CEO of Precigen, will represent the company.

What time is the Guggenheim Healthcare Talks event on February 12, 2021?

The event is scheduled for 11:30 AM ET.

How can I access the live webcast of the event?

The live webcast can be accessed through Precigen's website in the Events & Presentations section.

What is the focus area of Precigen's therapies?

Precigen develops gene and cell therapies mainly in immuno-oncology, autoimmune disorders, and infectious diseases.